Proteomics in Industry

Systems biology is a comprehensive quantitative analysis in which all the components of the biological system interact over a period of time. The Systems biology can be elaborated as “Integrative Biology” with the goal of being able to predict de novo biological outcomes. The term Epigenetics refers to the study of changes in the regulation of gene activity and expression that are not very much dependent on a DNA sequence. The Major difference between data generated in epigenomics study and expression study is the utility of the information of probe location in the genome For the Rms deviation of bond length & bond angle Deviation of bond lengths & angles. Ultimately all based on the geometry of small molecules. A survey taken by bcc research shows that The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019.

Some related Conferences:

4th International Conference on Clinical Pharmacy October 31-01, 2016 Las Vegas, USA; 5th International Conference on Computational Systems Biology August 22-23, 2016 Philadelphia, USA; 7th International Conference and exhibition on Pharmacovigilance & Clinical Trials September 19-21, 2016 Vienna, Austria; 8th International Conference and Exhibition on Pharmaceutics Novel Drug Delivery Systems March 07-09, 2016 Madrid, Spain; 2nd International Conference on Current Trends in Mass Spectrometry May 09-11, 2016 Chicago, USA; International Conference and Expo on Molecular & Cancer Biomarkers September 15-17, 2016 Berlin, Germany; Top-Down Mass Spectrometry Meeting September 21-22, 2015 Austria; Winter Plasma Spectrochemistry Conference January 10–16, 2016, USA; Asilomar Conference-Native Mass Spectrometry-based Structural Biology 16-20 October 2015 UK; 21st Mass Spectrometry Conference (IMSC 2016) August 20-26, 2016 Canada.

There is an increasing awareness of the potential of proteomic technologies to study production animals but the use of proteomic strategies to investigate animal health and disease has been limited by the lack of international coordination and collaboration. The COST action will form a network of the leading European scientists who are focused on farm animal proteomics, but it is also designed to encourage participation of researchers who are at an early stage of utilizing the range of proteomic methods which are becoming available. The state-of-the-art of proteomic techniques and their application within the plant-based food industry. The relevance of high throughput proteomic approaches is to increase insight and understanding of how food processing is affected by the physiology of the product and through this, to enable the optimization of the overall food production process. In the 20 years since its inception, the evolution of proteomics in pharmaceutical industry has mirrored the developments within academia and indeed other industries. From initial enthusiasm and subsequent disappointment in global protein expression profiling, pharma research saw the biggest impact when relating to more focused approaches, such as those exploring the interaction between proteins and drugs.

  • Proteomics in Pharmaceutical Industry
  • Proteomics in Food Industry
  • Farm Animal Proteomics
  • Industrial Protein chemistry
  • Machineries in Proteomics

Related Conference of Proteomics in Industry

Proteomics in Industry Conference Speakers